99
Views
8
CrossRef citations to date
0
Altmetric
Drug Profile

Lapatinib plus letrozole for postmenopausal patients with advanced HER2+/HR+ breast cancer

Pages 1549-1557 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hatem A Azim Jr & Martine J Piccart. (2010) Simultaneous targeting of estrogen receptor and HER2 in breast cancer. Expert Review of Anticancer Therapy 10:8, pages 1255-1263.
Read now

Articles from other publishers (7)

V. Guarneri, G. Griguolo, F. Miglietta, P.F. Conte, M.V. Dieci & F. Girardi. (2022) Survival after neoadjuvant therapy with trastuzumab–lapatinib and chemotherapy in patients with HER2-positive early breast cancer: a meta-analysis of randomized trials. ESMO Open 7:2, pages 100433.
Crossref
Eirini Thanopoulou, Leila Khader, Morena Caira, Andrew Wardley, Johannes Ettl, Federica Miglietta, Patrick Neven & Valentina Guarneri. (2020) Therapeutic Strategies for the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Positive (HR+/HER2+) Breast Cancer: A Review of the Current Literature. Cancers 12:11, pages 3317.
Crossref
C. Barrios, J.F. Forbes, W. Jonat, P. Conte, W. Gradishar, A. Buzdar, K. Gelmon, M. Gnant, J. Bonneterre, M. Toi, C. Hudis & J.F.R. Robertson. (2012) The sequential use of endocrine treatment for advanced breast cancer: where are we?. Annals of Oncology 23:6, pages 1378-1386.
Crossref
PierFranco Conte & Valentina Guarneri. (2012) The Next Generation of Biologic Agents: Therapeutic Role in Relation to Existing Therapies in Metastatic Breast Cancer. Clinical Breast Cancer 12:3, pages 157-166.
Crossref
István Láng, Zsuzsanna Kahán, Erika Hitre, Magdolna Dank, Gábor Rubovszky, Zsolt Horváth & Miklós Kásler. (2012) Modern pharmacological therapy of breast cancer. Orvosi Hetilap 153:2, pages 56-65.
Crossref
. (2011) Current World Literature. Current Opinion in Obstetrics & Gynecology 23:1, pages 58-63.
Crossref
Georgios Giamas, Yik L. Man, Heidrun Hirner, Joachim Bischof, Klaus Kramer, Kalimullah Khan, Sharmeen S. Lavina Ahmed, Justin Stebbing & Uwe Knippschild. (2010) Kinases as targets in the treatment of solid tumors. Cellular Signalling 22:7, pages 984-1002.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.